The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incorporating patient-reported outcome data into a hematopoietic cell transplant survival calculator.
 
Bronwen E. Shaw
Consulting or Advisory Role - Mallinckrodt (Inst); Orca Bio (Inst)
 
Kathryn E. Flynn
Stock and Other Ownership Interests - Biogen (I); Cerner (I); Gilead Sciences (I)
Consulting or Advisory Role - Inhibikase; Pfizer
 
Rachel Cusatis
No Relationships to Disclose
 
Anita D'Souza
Consulting or Advisory Role - Akcea Therapeutics; Bristol-Myers Squibb/Celgene; Janssen Oncology; Pfizer; Prothena
Research Funding - Abbvie; Caelum Biosciences (Inst); Janssen Oncology; Prothena (Inst); Regeneron; Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Imbrium Therapeutics
 
Betty Ky Hamilton
Consulting or Advisory Role - Equillium; Syndax
 
Mary M. Horowitz
Consulting or Advisory Role - Medac (Inst)
Research Funding - Actinium Pharmaceuticals (Inst); Amgen (Inst); Astellas Pharma (Inst); Biovitrum (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Chimerix (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Gamida Cell (Inst); GlaxoSmithKline (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead (Inst); Magenta Therapeutics (Inst); Mesoblast (Inst); Miltenyi Biotec (Inst); Novartis (Inst); Oncoimmune (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Sanofi (Inst); Seagen (Inst); Shire (Inst); Xenikos (Inst)
 
Deborah Mattila
No Relationships to Disclose
 
Rachel Phelan
Consulting or Advisory Role - Bluebird Bio
Research Funding - Amgen
 
Stephanie Lee
Honoraria - PER; Wolters Kluwer (I)
Consulting or Advisory Role - 4SC (I); Almirall Hermal GmbH (I); EMD Serono (I); Mallinckrodt/Therakos; Pfizer (I); Rain Therapeutics (I)
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb (I); EMD Serono (I); Incyte; Kadmon; Pfizer; Syndax
Patents, Royalties, Other Intellectual Property - Patent pending for high affinity T cell receptors that target the Merkel polyomavirus (I)
Other Relationship - National Marrow Donor Program; Society for Investigative Dermatology (SID) (I)
 
Ruta Brazauskas
No Relationships to Disclose